STOCK TITAN
  1. Home
  2. News
  3. DRMA

Dermata Therapeutics Inc - DRMA STOCK NEWS

IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols
clinical trial
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
earnings
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference
conferences
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
earnings
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics Announces Positive Feedback from FDA on the DMT310 Phase 3 Clinical Development Program in Moderate-to-Severe Acne
clinical trial
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
conferences
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Journal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Results
clinical trial
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics Announces Closing of $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
IMPACT
SENTIMENT
DRMA : Nasdaq DRMAW : Nasdaq
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
Stock DRMA logo
Dermata Therapeutics Inc

Nasdaq:DRMA

DRMA Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

DRMA Stock Data

Medicinal and Botanical Manufacturing
Manufacturing

About DRMA

dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.